Page last updated: 2024-11-13

bismuth salicylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bismuth Salicylate: MAGNESIUM SALICYLATE was entry term in SALICYLATES 1999-2005, indexed NM to SALICYLIC ACID 1981-1998 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54691487
MeSH IDM0019363

Synonyms (19)

Synonym
bismuth salicylate
salicylic acid, bismuth salt
benzoic acid, 2-hydroxy-, bismuth(3+) salt (3:1)
bismuth trisalicylate
k6ch6hc2o8 ,
unii-k6ch6hc2o8
7460-14-2
einecs 231-244-8
19034-57-2
bismuth(3+) salicylate
bismuth, tris(salicylato)-
5798-98-1
einecs 227-349-3
bismuth, tris(2-(hydroxy-.kappa.o)benzoato-.kappa.o)-
bismuth, tris(2-hydroxybenzoato-o1,o2)- bismuth, tris(salicylato)-
trisalicylic acid,usp standard
salicylic acid,bismuth salt
Q27282014
salicylic acid,bismuth(3+)salt
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (30.77)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's3 (23.08)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 61.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index61.46 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.16 (4.65)
Search Engine Demand Index149.45 (26.88)
Search Engine Supply Index3.03 (0.95)

This Compound (61.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies2 (13.33%)4.05%
Observational0 (0.00%)0.25%
Other11 (73.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]